Ranjit Kapadia bullish on Lupin, positive on Sanofi India

Ranjit Kapadia, Senior Vice President at Centrum Broking is bullish on Lupin and has a positive view on Sanofi India.

Ranjit Kapadia, Senior Vice President at Centrum Broking told CNBC-TV18, "We are bullish on  Lupin  and positive on  Sanofi India . Sanofi India is a company which had a maximum hit on the back of NPPA price control guidelines and it is going to get maximum benefit from this development."

On September 23, 2014 Lupin closed at Rs 1,356.05, down Rs 32.60, or 2.35 percent. It has touched an intraday high of Rs 1,404 and an intraday low of Rs 1,350.

Anda sedang membaca artikel tentang

Ranjit Kapadia bullish on Lupin, positive on Sanofi India

Dengan url

https://untukkesehatanda.blogspot.com/2014/09/ranjit-kapadia-bullish-on-lupin.html?m=0

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Ranjit Kapadia bullish on Lupin, positive on Sanofi India

namun jangan lupa untuk meletakkan link

Ranjit Kapadia bullish on Lupin, positive on Sanofi India

sebagai sumbernya